 |
propagermanium and irbesartan |
|---|---|
| Trade Name | |
| Orphan Indication | Focal segmental glomerulosclerosis |
| USA Market Approval | USA |
| USA Designation Date | 2015-12-09 00:00:00 |
| Sponsor | Dimerix Bioscience Ltd.;Level 2, 25 Flinders Lane;Melbourne |
| |
propagermanium and irbesartan |
|---|---|
| Trade Name | |
| Orphan Indication | Focal segmental glomerulosclerosis |
| USA Market Approval | USA |
| USA Designation Date | 2015-12-09 00:00:00 |
| Sponsor | Dimerix Bioscience Ltd.;Level 2, 25 Flinders Lane;Melbourne |